Effect of gefitinib on serum EGFR and CYFRA21-1 in patients with advanced non-small cell lung cancer

Changes of epidermal growth factor receptor (EGFR) and cytokeratin fragment antigen 21-1 (CYFRA21-1) in patients with advanced non-small cell lung cancer (NSCLC) before and after gefitinib treatment were observed to explore the significance of such changes. A total of 175 patients with advanced NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Hui, Hu, Yang, Xie, Tao, Jin, Caibao, Hu, Yanping, Yang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732996/
https://www.ncbi.nlm.nih.gov/pubmed/31516615
http://dx.doi.org/10.3892/ol.2019.10762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732996/
https://www.ncbi.nlm.nih.gov/pubmed/31516615
http://dx.doi.org/10.3892/ol.2019.10762

Ejemplares similares